French Medtechs Demand Attention To Ongoing Reimbursement Delays
Executive Summary
French medtech manufacturers are expecting positive results from recent ministerial efforts to make the national health-care products reimbursement agency, the CEPS, speed up its current slow handling of applications for products and services to enter commercial use in France's public-health system.